| pubmed-article:11884491 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:11884491 | lifeskim:mentions | umls-concept:C0439858 | lld:lifeskim |
| pubmed-article:11884491 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11884491 | pubmed:dateCreated | 2002-3-8 | lld:pubmed |
| pubmed-article:11884491 | pubmed:abstractText | This study was conducted to determine the ability of (18)F-FDG PET and conventional imaging (CI) to predict the outcomes in breast cancer patients who have previously undergone primary treatment. | lld:pubmed |
| pubmed-article:11884491 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11884491 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884491 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11884491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884491 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11884491 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11884491 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:CzerninJohann... | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:PhelpsMichael... | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:SilvermanDani... | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:VranjesevicDu... | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:FilmontJean... | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:MetaJoubinJ | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:RaoJyotsnaJ | lld:pubmed |
| pubmed-article:11884491 | pubmed:author | pubmed-author:ValkPeter EPE | lld:pubmed |
| pubmed-article:11884491 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11884491 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:11884491 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11884491 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11884491 | pubmed:pagination | 325-9 | lld:pubmed |
| pubmed-article:11884491 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:meshHeading | pubmed-meshheading:11884491... | lld:pubmed |
| pubmed-article:11884491 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11884491 | pubmed:articleTitle | Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. | lld:pubmed |
| pubmed-article:11884491 | pubmed:affiliation | Department of Nuclear Medicine, UCLA School of Medicine, Los Angeles, California 90095-6942, USA. | lld:pubmed |
| pubmed-article:11884491 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884491 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884491 | lld:pubmed |
